A blog about chemistry, drug development, science, and technology
Although small by normal standards, I did want to post, in my seemingly non-ending stream, about another merger. Starpharma is acquiring Dendritic Nanotechnologies for $6.9 million.
It would appear that Starpharma is acquiring them for their technologies and patents related to forming dendrimers.
Technorati Tags: pharma M&A, pharmaceutical deals, Dendritic Nanotechnologies, Starpharma
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 0.906 seconds